PPIST03288
Protein Information
| Protein_Chain | A |
|---|---|
| Protein_Sequence | IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT |
Peptide Information
| Peptide_Chain | B[auth L] |
|---|---|
| Peptide_Sequence | KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE |
| Peptide_Length | 52 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 2P16 |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.30 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa. |
|---|---|
| Release_Year | 2007 |
| PMID | 17914785 |
| DOI | 10.1021/jm070245n |